MedPacto Inc (235980.KQ) stock: key figures, P/E, revenue and dividend

Energy · Coal & Consumable Fuels · South Korea

Price
2,920.00 KRW
Market cap
100.08 bn KRW
P/E (2025)
–
P/S (2025)
25.67
Dividend yield
0.00 %
Net margin
-328.61 %
Return on equity (ROE)
-27.86 %
Return on assets (ROA)
-26.33 %

MedPacto Inc financials

Fiscal year20242025
Revenue0.00 KRW3.90 bn KRW
Gross profit0.00 KRW385.16 m KRW
Operating income-21.82 bn KRW-14.02 bn KRW
EBIT-20.05 bn KRW-12.69 bn KRW
Net income-20.14 bn KRW-12.81 bn KRW
Diluted EPS – continuing operations-587.61 KRW-373.76 KRW

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About MedPacto Inc

MedPacto, Inc. engages in the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.